Literature DB >> 15979081

Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women.

Dogan Erdogan1, Hakan Gullu, Erkan Yildirim, Derya Tok, Ismail Kirbas, Ozgur Ciftci, Semra Topcu Baycan, Haldun Muderrisoglu.   

Abstract

BACKGROUND: Elevated levels of low-density lipoprotein (LDL) cholesterol and its oxidative modification have been described to be involved in the process of atherogenesis. Bilirubin, an antioxidant, prevents oxidative modification of LDL and therefore may protect from atherosclerosis and coronary heart disease (CHD). Impaired brachial artery flow-mediated dilatation (FMD), which means endothelial dysfunction (ED) and carotid intima-media thickness (IMT) are predictors for the development and progression of atherosclerosis. In the present study, FMD and IMT were studied in healthy subjects with lower and higher serum bilirubin concentrations in physiological ranges.
METHODS: Ninety-one healthy subjects between 25 and 45 years of age (47 with lower and 44 with higher serum bilirubin concentrations) were included in this study. Carotid IMT and brachial artery flow-mediated dilatation was measured by means of high-resolution vascular ultrasound. FMD was assessed by establishing reactive hyperemia and endothelium-independent dilatation (EID) was determined by using sublingual isosorbide dinitrate.
RESULTS: EDD in subjects with lower serum bilirubin concentrations was significantly worse than in those with higher serum bilirubin concentrations (11.6+/-4.4% versus 7.2+/-4.7%, respectively, p<0.0001). EID measurements were not significantly different between the groups (16+/-5.1% versus 16.8+/-7%, respectively). In addition, carotid IMT was significantly greater in subjects with lower serum bilirubin concentrations (0.5+/-0.13 mm versus 0.42+/-0.07 mm, p<0.0001). Furthermore, FMD in women with lower serum bilirubin concentrations was significantly lower than in women with higher serum bilirubin concentrations (11.5+/-4.9% and 17.5+/-4.7%, respectively, p<0.001). Accordingly, men with lower serum bilirubin concentrations had significantly lower FMD as compared to hyperbilirubinemic ones (11.7+/-3.6% versus 16.7+/-4.8%, respectively, p=0.009). Conversely, carotid IMT was significantly greater in both women and men with lower serum bilirubin concentrations compared to the subjects with elevated serum bilirubin concentrations (0.51+/-0.08 versus 0.41+/-0.08, p<0.001; 0.55+/-0.12 versus 0.40+/-0.07, p=0.002, in women and men, respectively).
CONCLUSION: The healthy subjects with lower serum bilirubin concentrations show significant ED and increased carotid IMT, which are predictors for atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979081     DOI: 10.1016/j.atherosclerosis.2005.05.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  41 in total

1.  Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study.

Authors:  Cheryl McDonald; Jonathan Uy; Wenhua Hu; Victoria Wirtz; Salome Juethner; David Butcher; Donnie McGrath; Awny Farajallah; Graeme Moyle
Journal:  AIDS Patient Care STDS       Date:  2012-03-09       Impact factor: 5.078

2.  Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV-infected adults on stable antiretroviral therapy.

Authors:  Co Hileman; Ct Longenecker; Tl Carman; Gl Milne; D E Labbato; Nj Storer; Ca White; Ga McComsey
Journal:  HIV Med       Date:  2012-05-25       Impact factor: 3.180

3.  Hyperbilirubinemia and intermittent lower urinary tract dysfunction.

Authors:  Vesna Stojanović; Tamara Vukavić
Journal:  Indian J Pediatr       Date:  2011-01-04       Impact factor: 1.967

4.  Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease.

Authors:  Arno Lingenhel; Barbara Kollerits; Johannes P Schwaiger; Steven C Hunt; Richard Gress; Paul N Hopkins; Veit Schoenborn; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-08-26       Impact factor: 4.032

5.  Hyperbilirubinemia and intermittent lower urinary tract dysfunction: a story.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

6.  Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?

Authors:  Pernette R W de Sauvage Nolting; D Meeike Kusters; Barbara A Hutten; John J P Kastelein
Journal:  J Lipid Res       Date:  2011-06-23       Impact factor: 5.922

7.  Association of Serum Bilirubin with SYNTAX Score and Future Cardiovascular Events in Patients Undergoing Coronary Intervention.

Authors:  Chun-Chin Chang; Chien-Yi Hsu; Po-Hsun Huang; Chia-Hung Chiang; Shao-Sung Huang; Hsin-Bang Leu; Chin-Chou Huang; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

8.  Association of serum total bilirubin levels with the severity, extent and subtypes of coronary atherosclerotic plaques detected by coronary CT angiography.

Authors:  Uğur Canpolat; Kudret Aytemir; Hikmet Yorgun; Tuncay Hazırolan; Ergün Barış Kaya; Levent Şahiner; Hamza Sunman; Lale Tokgözoğlu; Giray Kabakcı; Ali Oto
Journal:  Int J Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 2.357

Review 9.  Hyperbilirubinemia, Hypertension, and CKD: the Links.

Authors:  Ibrahim Mortada
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

10.  Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  K H Chan; R L O'Connell; D R Sullivan; L S Hoffmann; K Rajamani; M Whiting; M W Donoghoe; M Vanhala; A Hamer; B Yu; R Stocker; M K C Ng; A C Keech
Journal:  Diabetologia       Date:  2013-01-17       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.